AU2001297988B2 - Nucleic acid adjuvants - Google Patents

Nucleic acid adjuvants Download PDF

Info

Publication number
AU2001297988B2
AU2001297988B2 AU2001297988A AU2001297988A AU2001297988B2 AU 2001297988 B2 AU2001297988 B2 AU 2001297988B2 AU 2001297988 A AU2001297988 A AU 2001297988A AU 2001297988 A AU2001297988 A AU 2001297988A AU 2001297988 B2 AU2001297988 B2 AU 2001297988B2
Authority
AU
Australia
Prior art keywords
composition
nucleic acid
antigen
subunit
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2001297988A
Other languages
English (en)
Other versions
AU2001297988A1 (en
Inventor
Joshua E. Arrington
Joel R. Haynes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of AU2001297988A1 publication Critical patent/AU2001297988A1/en
Application granted granted Critical
Publication of AU2001297988B2 publication Critical patent/AU2001297988B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001297988A 2000-11-27 2001-11-26 Nucleic acid adjuvants Ceased AU2001297988B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72431500A 2000-11-27 2000-11-27
US09/724,315 2000-11-27
PCT/US2001/043151 WO2003004055A2 (en) 2000-11-27 2001-11-26 Nucleic acid adjuvants

Publications (2)

Publication Number Publication Date
AU2001297988A1 AU2001297988A1 (en) 2003-05-22
AU2001297988B2 true AU2001297988B2 (en) 2006-10-26

Family

ID=24909936

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001297988A Ceased AU2001297988B2 (en) 2000-11-27 2001-11-26 Nucleic acid adjuvants

Country Status (16)

Country Link
EP (1) EP1379273B1 (enExample)
JP (1) JP4221289B2 (enExample)
KR (1) KR20040045391A (enExample)
CN (1) CN1317034C (enExample)
AT (1) ATE442858T1 (enExample)
AU (1) AU2001297988B2 (enExample)
BR (1) BR0115646A (enExample)
CA (1) CA2429708A1 (enExample)
DE (1) DE60139959D1 (enExample)
DK (1) DK1379273T3 (enExample)
ES (1) ES2332261T3 (enExample)
IL (2) IL156041A0 (enExample)
MX (1) MXPA03004638A (enExample)
NZ (1) NZ526175A (enExample)
PT (1) PT1379273E (enExample)
WO (1) WO2003004055A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1685251E (pt) 2003-10-10 2014-04-15 Powderject Vaccines Inc Construções de ácido nucleico
EP1716173B8 (en) 2004-02-11 2012-06-27 Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. Carcinoembryonic antigen fusion protein and uses thereof
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
JP5311508B2 (ja) * 2008-05-07 2013-10-09 国立大学法人大阪大学 非共有結合型コラーゲン架橋剤
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
CN103249401B (zh) 2010-09-15 2016-01-20 兰德尔·J·米斯尼 使用细菌毒素衍生的转运序列递送生物活性剂的系统和方法
CN103060253A (zh) * 2013-01-24 2013-04-24 麻丽丹 霍乱弧菌ctxAB基因的质粒克隆菌株以及制备方法和应用
PT3139965T (pt) 2014-05-07 2021-12-27 Applied Molecular Transp Llc Moléculas de fusão derivadas de toxinas cholix para administração oral de carga biologicamente ativa
SI3762009T1 (sl) 2018-03-08 2023-03-31 Applied Molecular Transport Inc. Iz toksinov izpeljani dostavni konstrukti za peroralno dostavo
DK3650037T3 (da) 2018-11-07 2022-05-02 Applied Molecular Transport Inc Indgivelseskonstrukter til transcytose og tilhørende fremgangsmåder
MX2022001975A (es) 2019-08-16 2022-03-11 Applied Molecular Transport Inc Composiciones, formulaciones y produccion y purificacion de interleucinas.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
GB9416663D0 (en) 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
JP3853360B2 (ja) 1994-10-24 2006-12-06 パウダージェクト リサーチ リミテッド 粒子供給装置
GB9426379D0 (en) 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
US6056960A (en) * 1995-06-07 2000-05-02 Kaslow; Harvey R. Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization

Also Published As

Publication number Publication date
MXPA03004638A (es) 2004-04-20
WO2003004055A3 (en) 2003-11-20
ES2332261T3 (es) 2010-02-01
ATE442858T1 (de) 2009-10-15
DK1379273T3 (da) 2009-11-09
JP4221289B2 (ja) 2009-02-12
JP2004536107A (ja) 2004-12-02
NZ526175A (en) 2006-01-27
WO2003004055A2 (en) 2003-01-16
BR0115646A (pt) 2005-12-13
CN1537013A (zh) 2004-10-13
CN1317034C (zh) 2007-05-23
KR20040045391A (ko) 2004-06-01
EP1379273A2 (en) 2004-01-14
IL156041A0 (en) 2003-12-23
EP1379273B1 (en) 2009-09-16
DE60139959D1 (de) 2009-10-29
IL156041A (en) 2010-05-17
PT1379273E (pt) 2009-11-27
CA2429708A1 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
US7699801B2 (en) Advanced genetic vaccines
US20030185835A1 (en) Adjuvant for vaccines
US20060088542A1 (en) Imidazoquinoline adjuvants for vaccines
AU2001297988B2 (en) Nucleic acid adjuvants
AU2001297988A1 (en) Nucleic acid adjuvants
US20070026015A1 (en) Method
US20070042050A1 (en) Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression
US20070237789A1 (en) DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
AU4479700A (en) Nucleic acid immunization
US20060019921A1 (en) Nucleic acid adjuvants
AU780448C (en) Adjuvanted genetic vaccines
US20040082530A1 (en) Nucleic acid immunization
AU785066B2 (en) DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
EP1240343A2 (en) Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression
EP1913957B1 (en) Adjuvanted genetic vaccines

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired